Combined corticosteroid and long-acting beta2-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Combined corticosteroid and long-acting beta2-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease

Published:2013-08-30 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Nannini Luis Javier¹,Poole Phillippa²,Milan Stephen J³,Kesterton Annabel⁴

Affiliation:

1. Hospital E Peron; Pulmonary Section; Ruta 11 Y Jm Estrada G. Baigorria Santa Fe - Rosario Argentina 2152

2. University of Auckland; Department of Medicine; Private Bag 92019 Auckland New Zealand

3. St George's, University of London; Population Health Sciences and Education; London UK

4. St George's University of London; Population Health Sciences and Education; London UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference187 articles.

1. Bourbeau J Christodoulopoulos P Maltais F Yamauchi Y Olivenstein R Hamid Q Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial Thorax 2007 938 43

2. AstraZeneca SD A placebo-controlled 12-month efficacy study of the fixed combination budesonide/formoterol compared to budesonide and formoterol as monotherapies in patients with chronic obstructive pulmonary disease (COPD) AstraZeneca Clinical Trials 2002

3. Borgstrom L Asking L Olsson H Peterson S Lack of interaction between disease severity and therapeutic response with budesonide/formoterol in a single inhaler [Abstract] American Thoracic Society 100th International Conference; May 21-26; 2004, Orlando, Florida. C22 [Poster 505]

4. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease;Calverley;European Respiratory Journal,2003

5. Budesonide/formoterol reduces the use of oral corticosteroids in the treatment of COPD [Abstract];Calverley;European Respiratory Journal,2003

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Adherence and Health Status of Patients With COPD Under Treatment With Salmeterol/Fluticasone via the Elpenhaler® Device: The AHEAD Study;The Clinical Respiratory Journal;2024-07

2. Network meta-analysis of the efficacy and safety of monoclonal antibodies and traditional conventional dichotomous agents for chronic obstructive pulmonary disease;Frontiers in Medicine;2024-02-13

3. Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History;Biomolecules;2024-02-06

4. Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B₂-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study;BMJ Open;2024-02

5. Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS;Pragmatic and Observational Research;2024-01